240 related articles for article (PubMed ID: 38585915)
1. Traumatic injury causes selective degeneration and TDP-43 mislocalization in human iPSC-derived
Martin EJ; Santacruz C; Mitevska A; Jones IE; Krishnan G; Gao FB; Finan JD; Kiskinis E
bioRxiv; 2024 Mar; ():. PubMed ID: 38585915
[TBL] [Abstract][Full Text] [Related]
2. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
[TBL] [Abstract][Full Text] [Related]
3. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
4. Repeated mild traumatic brain injury triggers pathology in asymptomatic C9ORF72 transgenic mice.
Kahriman A; Bouley J; Tuncali I; Dogan EO; Pereira M; Luu T; Bosco DA; Jaber S; Peters OM; Brown RH; Henninger N
Brain; 2023 Dec; 146(12):5139-5152. PubMed ID: 37527465
[TBL] [Abstract][Full Text] [Related]
5. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Immune Activation by
Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
[TBL] [Abstract][Full Text] [Related]
7. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
[TBL] [Abstract][Full Text] [Related]
8. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
10. Toxic gain-of-function mechanisms in
Beckers J; Van Damme P
Autophagy; 2024 Apr; ():1-3. PubMed ID: 38615685
[TBL] [Abstract][Full Text] [Related]
11. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
12. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD.
Dafinca R; Barbagallo P; Farrimond L; Candalija A; Scaber J; Ababneh NA; Sathyaprakash C; Vowles J; Cowley SA; Talbot K
Stem Cell Reports; 2020 May; 14(5):892-908. PubMed ID: 32330447
[TBL] [Abstract][Full Text] [Related]
13. Emerging Mechanisms Underpinning Neurophysiological Impairments in
Pasniceanu IS; Atwal MS; Souza CDS; Ferraiuolo L; Livesey MR
Front Cell Neurosci; 2021; 15():784833. PubMed ID: 34975412
[TBL] [Abstract][Full Text] [Related]
14. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
Ababneh NA; Scaber J; Flynn R; Douglas A; Barbagallo P; Candalija A; Turner MR; Sims D; Dafinca R; Cowley SA; Talbot K
Hum Mol Genet; 2020 Aug; 29(13):2200-2217. PubMed ID: 32504093
[TBL] [Abstract][Full Text] [Related]
15. Moderate intrinsic phenotypic alterations in
Lorenzini I; Alsop E; Levy J; Gittings LM; Lall D; Rabichow BE; Moore S; Pevey R; Bustos LM; Burciu C; Bhatia D; Singer M; Saul J; McQuade A; Tzioras M; Mota TA; Logemann A; Rose J; Almeida S; Gao FB; Marks M; Donnelly CJ; Hutchins E; Hung ST; Ichida J; Bowser R; Spires-Jones T; Blurton-Jones M; Gendron TF; Baloh RH; Van Keuren-Jensen K; Sattler R
Front Cell Neurosci; 2023; 17():1179796. PubMed ID: 37346371
[TBL] [Abstract][Full Text] [Related]
16. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
[TBL] [Abstract][Full Text] [Related]
17.
Broce IJ; Sirkis DW; Nillo RM; Bonham LW; Lee SE; Miller B; Castruita P; Sturm VE; Sugrue LS; Desikan RS; Yokoyama JS
bioRxiv; 2023 Aug; ():. PubMed ID: 37503230
[TBL] [Abstract][Full Text] [Related]
18. Knocking out C9ORF72 Exacerbates Axonal Trafficking Defects Associated with Hexanucleotide Repeat Expansion and Reduces Levels of Heat Shock Proteins.
Abo-Rady M; Kalmbach N; Pal A; Schludi C; Janosch A; Richter T; Freitag P; Bickle M; Kahlert AK; Petri S; Stefanov S; Glass H; Staege S; Just W; Bhatnagar R; Edbauer D; Hermann A; Wegner F; Sterneckert JL
Stem Cell Reports; 2020 Mar; 14(3):390-405. PubMed ID: 32084385
[TBL] [Abstract][Full Text] [Related]
19. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
